You are here

Dietary Therapy with the Crohn’s Disease Exclusion Diet is a Successful Strategy for Induction of Remission in Children and Adults Failing Biological Therapy.

Dietary Therapy with the Crohn’s Disease Exclusion Diet is a Successful Strategy for Induction of Remission in Children and Adults Failing Biological Therapy. J Crohns Colitis. 2017 May 19;: Authors: Sigall Boneh R, Sarbagili-Shabat C, Yanai H, Chermesh I, Ben Avraham S, Boaz M, Levine A Abstract Background: Loss of response (LoR) to biologics in Crohn’s disease (CD) is a significant clinical problem. Dietary therapy as a treatment strategy in this setting has not been previously reported. We report the use of dietary strategies using enteral nutrition coupled with the…

Read More

Fermentable carbohydrates (FODMAPs) exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial.

Fermentable carbohydrates (FODMAPs) exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial. J Crohns Colitis. 2017 May 19;: Authors: Cox SR, Prince AC, Myers CE, Irving PM, Lindsay JO, Lomer MC, Whelan K Abstract Background and Aims: Preliminary evidence suggests fermentable carbohydrate restriction might ameliorate functional gastrointestinal symptoms (FGS) in quiescent inflammatory bowel disease (IBD). Our aim was to determine whether fermentable carbohydrates exacerbate FGS in quiescent IBD using a randomised, double-blinded, placebo-controlled, cross-over, re-challenge trial. Methods: Patients with quiescent IBD and…

Read More

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. J Crohns Colitis. 2017 Jan 28;: Authors: Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F, European Crohn’s and Colitis Organisation [ECCO] PMID: 28513805 [PubMed – as supplied by publisher] PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/28513805?dopt=Abstract

Read More

Chronic enteropathy associated with SLCO2A1 gene (CEAS) – Characterization of an enteric disorder to be considered in the differential diagnosis of Crohn’s disease.

Chronic enteropathy associated with SLCO2A1 gene (CEAS) – Characterization of an enteric disorder to be considered in the differential diagnosis of Crohn’s disease. J Crohns Colitis. 2017 May 16;: Authors: Hosoe N, Ohmiya N, Hirai F, Umeno J, Esaki M, Yamagami H, Onodera K, Bamba S, Imaeda H, Yanai S, Hisamatsu T, Ogata H, Matsumoto T, CEAS atlas group Abstract Small intestinal ulcers include mucosal damage caused by drugs, particularly nonsteroidal anti-inflammatory drugs (NSAIDs), infectious diseases, and idiopathic inflammatory bowel disease. Previously, a group of Japanese investigators reported an unusual…

Read More

ECCO-ESCP Consensus on Surgery for Crohn’s Disease.

ECCO-ESCP Consensus on Surgery for Crohn’s Disease. J Crohns Colitis. 2017 May 11;: Authors: Bemelman WA, Warusavitarne J, Sampietro GM, Serclova Z, Zmora O, Luglio G, de Buck van Overstraeten A, Burke JP, Buskens CJ, Francesco C, Amil Dias J, Eliakim R, Elosua T, Gecim IE, Kolacek S, Kierkus J, Kolho KL, Lefevre JH, Millan M, Panis Y, Pinkney T, Russell RK, Shwaartz C, Vaizey C, Yassin N, D’Hoore A, European Crohn’s and Colitis Organisation (ECCO), European Society of Coloproctology (ESCP) PMID: 28498901 [PubMed – as supplied by publisher] PubMed…

Read More

Patient education in a 14 month randomized trial fails to improve adherence in ulcerative colitis: Influence of demographic and clinical parameters on non-adherence.

Patient education in a 14 month randomized trial fails to improve adherence in ulcerative colitis: Influence of demographic and clinical parameters on non-adherence. J Crohns Colitis. 2017 May 09;: Authors: Nikolaus S, Schreiber S, Siegmund B, Bokemeyer B, Bästlein E, Bachmann O, Görlich D, Hofmann U, Schwab M, Kruis W Abstract Background: Recent observational studies document that non-adherence to mesalamine therapy during remission is frequent. Aim: To investigate patient impact of patient education using objective assessments of adherence. Design: A 14-month randomized, prospective clinical trial of adherence to mesalamine was…

Read More
<< Go Back